Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05299606 · ClinicalTrials.gov registry record · NA

POWER Study (Prospective Transbronchial Microwave + Robotic-Assisted Bronchoscopy)

A NA study, sponsored by Ethicon.

Terminated
Registry status
NA
Development phase
12
Enrollment target

NCT05299606 is a NA study that was terminated before completion, run by Ethicon. The registered enrollment target is 12 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05299606, a NA study, was terminated before completion, sponsored by Ethicon.

TERMINATED
Registry status
NA
Development phase
12 participants
Enrollment target

Study Summary

This is a prospective, multicenter, single-arm study on transbronchial microwave ablation using the NEUWAVE FLEX Microwave Ablation System and Accessories on oligometastatic tumors in the peripheral lung, guided by the Auris MONARCH Platform for visualization and access while using cone beam CT (computed tomography) to confirm probe tip placement and final ablation zone. The primary endpoint is Technique Efficacy, assessed 30-days post-ablation via CT imaging.

Interventions

  • DEVICE Transbronchial Microwave Ablation

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2022-10-21
Est. Completion 2024-10-18
Phase NA

Sponsor

Ethicon

38 total trials

What the Registry Record Tells You About NCT05299606

The ClinicalTrials.gov registry entry for NCT05299606 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ethicon, which has 38 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Transbronchial Microwave Ablation is the first listed.

NCT05299606 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05299606 about?

NCT05299606 is a clinical study titled "POWER Study (Prospective Transbronchial Microwave + Robotic-Assisted Bronchoscopy)". This is a prospective, multicenter, single-arm study on transbronchial microwave ablation using the NEUWAVE FLEX Microwave Ablation System and Accessories on oligometastatic tumors in the peripheral lung, guided by the Auris MONARCH Platform for visualization and access while using cone beam CT (com...

What is the current status of trial NCT05299606?

This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2022-10-21. Estimated completion is 2024-10-18.

What interventions are being tested in trial NCT05299606?

The interventions under investigation include: Transbronchial Microwave Ablation (DEVICE).

Who is sponsoring clinical trial NCT05299606?

This trial is sponsored by Ethicon, which has 38 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.